RxDoctor Payments Data

Kevin Wansor, PA

Medical · Upland, PANPI 1588853675

Payments from drug & device makers

$909in general payments, 2019–2025

Across 42 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$238
  • AstraZeneca$134
  • Vifor Pharma, Inc.$130
  • Otsuka America Pharmaceutical, Inc.$124
  • Ardelyx, Inc.$48
  • Novartis$40
  • plus $194 from 8 others

What the payments were for

  • Food & beverage$909100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$909 in reported general payments places this provider in the 65th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$5,511
Medicare patients
27
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol26$19,021
Calcium Acetate18$1,113
Bumetanide25$1,096
Calcitriol48$920
Losartan Potassium82$878
Amlodipine Besylate92$854
Hydralazine Hcl55$744
Sevelamer Carbonate13$639
Nifedipine ErNifedipine13$589
Atorvastatin Calcium46$540
Doxazosin Mesylate30$440
Metoprolol Succinate15$337
Allopurinol29$335
Labetalol Hcl16$325
Furosemide56$310

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$134$19,02126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Upland

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →